NCT06332625View on ClinicalTrials.gov

The Fingerprinting of Inherited Leukoencephalopathies: A New Brain Imaging, Genetic and Clinical Assessment

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 22, 2023

Primary Completion Date

February 5, 2024

Study Completion Date

November 22, 2025

Conditions
Leukoencephalopathies
Interventions
DIAGNOSTIC_TEST

Brain quantitative magnetic resonance imaging

Identification and predictability of early structural and metabolic markers from 3T and 7T quantitative magnetic resonance imaging (qMRI)

Trial Locations (3)

20132

RECRUITING

Ospedale San Raffaele, Milan

20133

RECRUITING

Fondazione Istituto Neurologico Carlo Besta, Milan

94018

RECRUITING

IRCCS Associazione Oasi Maria SS Troina, Troina

Sponsors
All Listed Sponsors
collaborator

Oasi Research Institute-IRCCS

OTHER

collaborator

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

OTHER

collaborator

IRCCS Ospedale San Raffaele

OTHER

lead

IRCCS Fondazione Stella Maris

OTHER

NCT06332625 - The Fingerprinting of Inherited Leukoencephalopathies: A New Brain Imaging, Genetic and Clinical Assessment | Biotech Hunter | Biotech Hunter